GAM Holding’s Integra LifeSciences IART Stock Holding History

GAM Holding’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,800	Closed	-$2.1M	–	838
2018 Q3	$2.1M	Hold	31,800	–	–	0.08%	280
2018 Q2	$2.05M	Hold	31,800	–	–	0.07%	280
2018 Q1	$1.76M	Sell	31,800 -47,000	-60%	-$2.46M	0.06%	317
2017 Q4	$3.77M	Hold	78,800	–	–	0.12%	216
2017 Q3	$3.98M	Sell	78,800 -20,800	-21%	-$1.07M	0.17%	167
2017 Q2	$5.43M	Hold	99,600	–	–	0.08%	299
2017 Q1	$4.2M	Hold	99,600	–	–	0.07%	360
2016 Q4	$4.27M	Hold	99,600	–	–	0.07%	300
2016 Q3	$4.11M	Sell	99,600 -99,600	-50%	-$4.17M	0.07%	299
2016 Q2	$7.95M	Buy	+199,200	New	+$7.17M	0.12%	207

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Holding's IART Position: Q4 2018 in Review

GAM Holding sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 31,800 shares — an estimated $2.1M sold.

GAM Holding first reported a position in IART in Q2 2016 and held it in 10 quarters. The position peaked at $7.95M in Q2 2016. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

GAM Holding reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
GAM Holding sold 31,800 Integra LifeSciences shares in Q4 2018, an estimated $2.1M.
GAM Holding first reported a position in Integra LifeSciences in Q2 2016 and held it in 10 quarters.
GAM Holding's Integra LifeSciences position peaked at $7.95M in Q2 2016.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on GAM Holding's 13F filing for Q4 2018, filed 8 Feb 2019.